Colorectal cancer
RecruitingStudy of Recovery After Surgery for Colorectal Cancer Using Lidocaine and Ropivacaine in Patients Undergoing Laparoscopic Colorectal Cancer Surgery
Study of Recovery After Surgery for Colorectal Cancer Using Lidocaine and Ropivacaine in Patients Undergoing Laparoscopic Colorectal Cancer Surgery
- Disease:Colorectal cancer
- Substances:ParecoxibRopivacaine Hydrochloride
France- Participants:18–64 years · 65+ years
- Substances:Parecoxib
- Sponsor:Centre Hospitalier Universitaire Amiens Picardie

